3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow RBP4 Pty Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85 Tinlarebant (LBS-008) - Healthy Volunteer, Dry Age-related Macular Degeneration | Phase 1 | Completed | RBP4 Pty Ltd | 15 | 2022-11-28 | 2023-02-23 |
| This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease tinlarebant - Stargardt Disease | Phase 1 / Phase 2 | Completed | RBP4 Pty Ltd | 13 | 2021-03-12 | 2024-04-12 |
| Safety and Tolerability Study of LBS-008 in Healthy Adult Subjects After Single and Multiple Doses LBS-008, Placebos - Healthy Volunteer | Phase 1 | Completed | RBP4 Pty Ltd | 71 | 2018-11-15 | 2020-01-07 |
Australia (3) · Taiwan (1)
Sam Francis (1)